Factors Predicting Prostatic Biopsy Gleason Sum Under Grading

Journal of Urology

Volumn 182, Issue 1, 2009, Pages 118-124

  Stackhouse, Danielle A ^a   Sun, Leon ^a   Schroeck, Florian R ^a   Jayachandran, Jayakrishnan ^a   Caire, Arthur A ^a   Acholo, Cyril O ^a   Robertson, Cary N ^a   Albala, David M ^a   Polascik, Thomas J ^a   Donatucci, Craig F ^a   Maloney, Kelly E ^a   Moul, Judd W ^a  

^a DUKE UNIVERSITY   (United States)

Author keywords

biopsy; diagnosis; nomograms; prostate; prostatic neoplasms

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; BODY MASS; CANCER GRADING; CONTROLLED STUDY; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROGNOSIS; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATECTOMY;

AGED; BIOPSY, NEEDLE; COHORT STUDIES; CONFIDENCE INTERVALS; FROZEN SECTIONS; HUMANS; IMMUNOHISTOCHEMISTRY; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NOMOGRAMS; ODDS RATIO; PREDICTIVE VALUE OF TESTS; PREOPERATIVE CARE; PROBABILITY; PROGNOSIS; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; TREATMENT OUTCOME; TUMOR BURDEN;

EID: 67349259158     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.juro.2009.02.127     Document Type: Article

References (20)

1. Partin A.W., Yoo J., Carter H.B., Pearson J.D., Chan D.W., Epstein J.I., et al. The use of prostate specific antigen, clinical stage and Gleason score to predict pathological stage in men with localized prostate cancer. J Urol 150 (1993) 110
2. Epstein J.I., Pizov G., and Walsh P.C. Correlation of pathological findings with progression after radical retropubic prostatectomy. Cancer 71 (1993) 3582
3. Lattouf J.B., and Saad F. Gleason score on biopsy: is it reliable for predicting the final grade on pathology?. BJU Int 90 (2002) 694
4. King C.R. Patterns of prostate cancer biopsy grading: trends and clinical implications. Int J Cancer 90 (2000) 305
5. Isariyawongse B.K., Sun L., Bañez L.L., Robertson C., Polascik T.J., Maloney K., et al. Significant discrepancies between diagnostic and pathologic Gleason sums in prostate cancer: the predictive role of age and prostate-specific antigen. Urology 72 (2008) 882
6. Cookson M.S., Fleshner N.E., Soloway S.M., and Fair W.R. Correlation between Gleason score of needle biopsy and radical prostatectomy specimen: accuracy and clinical implications. J Urol 157 (1997) 559
7. Hong S.K., Yu J.H., Han B.K., Chang I.H., Jeong S.J., Byun S.S., et al. Association of prostate size and tumor grade in Korean men with clinically localized prostate cancer. Urology 70 (2007) 91
8. Egevad L., Norlen B.J., and Norberg M. The value of multiple core biopsies for predicting the Gleason score of prostate cancer. BJU Int 88 (2001) 716
9. Mills S.E., and Fowler J.E. Gleason histologic grading of prostatic carcinoma. Correlations between biopsy and prostatectomy specimens. Cancer 57 (1986) 346
10. Scherr D., Swindle P.W., and Scardino P.T. National Comprehensive Cancer Network guidelines for the management of prostate cancer. Urology 61 (2003) 14
11. Freedland S.J., Kane C.J., Amling C.L., Aronson W.J., Terris M.K., and Presti J.C. Upgrading and downgrading of prostate needle biopsy specimens: risk factors and clinical implications. Urology 69 (2006) 495
12. Klotz L. Active surveillance for prostate cancer: for whom?. J Clin Oncol 23 (2005) 8165
13. Nag S., Beyer D., Friedland J., Grimm P., and Nath R. American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44 (1999) 789
14. Hardie C., Parker C., Norman A., Eeles R., Horwich A., Huddart R., et al. Early outcomes of active surveillance for localized prostate cancer. BJU Int 95 (2005) 956
15. Albertsen P.C., Hanley J.A., Barrows G.H., Penson D.F., Kowalczyk P.D., Sanders M.M., et al. Prostate cancer and the Will Rogers Phenomenon. J Natl Cancer Inst 97 (2006) 1248
16. Allsbrook Jr. W.C., Mangold K.A., Johnson M.H., Lane R.B., Lane C.G., and Epstein J.I. Interobserver reproducibility of Gleason grading of prostatic carcinoma: general pathologist. Hum Pathol 32 (2001) 81
17. Emiliozzi P., Maymone S., Paterno A., Scarpone P., Amini M., Proietti G., et al. Increased accuracy of biopsy Gleason score obtained by extended needle biopsy. J Urol 172 (2004) 2224
18. Kattan M., Eastham J.A., Stapleton A.M., Wheeler T.M., and Scardino P.T. A preoperative nomogram for disease recurrence following radical prostatectomy for prostate cancer. J Natl Cancer Inst 90 (1998) 766
19. Stephenson A.J., Scardino P.T., Eastham J.A., Bianco Jr. F.J., Dotan Z.A., Fearn P.A., et al. Preoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Natl Cancer Inst 98 (2006) 715
20. Chun F.K., Steuber T., Erbersdobler A., Currlin E., Walz J., Schlomm T., et al. Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology. Eur Urol 49 (2006) 820